ALTO-100 PO tablet

DRUG2 trials

Sponsors

Alto Neuroscience

Conditions

Major Depressive DisorderPost Traumatic Stress Disorder

Phase 2

ALTO-100 in MDD and/or PTSD

CompletedNCT05117632

Alto NeuroscienceMajor Depressive Disorder, Post Traumatic Stress Disorder

Start: 2021-12-20End: 2022-12-09Updated: 2023-12-01

Pilot Decentralized Trial

CompletedNCT05419869

Alto NeuroscienceMajor Depressive Disorder

Start: 2022-06-01End: 2023-01-26Updated: 2024-01-18